2025-07-04 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data.  I'll provide summaries with key figures and some interpretation.

**1. Performance vs. S&P 500 (VOO) & Alpha/Beta Analysis**

*   **Ticker:** PG (Procter & Gamble Co)
*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.

*   **Cumulative Return (PG):** 51.59%
*   **Cumulative Return (VOO):** 95.42%
*   **Absolute Divergence:** -43.8% (PG underperformed VOO by 43.8% cumulatively)
*   **Relative Divergence:** 0.0 (Current divergence is at the lowest end of its historical range compared to VOO)

*   **Alpha/Beta Analysis:**

    | Year       | CAGR  | MDD   | Alpha  | Beta  | Cap(B) |
    |------------|-------|-------|--------|-------|--------|
    | 2015-2017  | 21.0% | 7.9%  | -8.0%  | 0.0   | 216.2  |
    | 2016-2018  | 5.0%  | 56.7% | -13.0% | 0.1   | 216.3  |
    | 2017-2019  | 30.0% | 56.7% | 0.0%   | 0.5   | 293.9  |
    | 2018-2020  | 38.0% | 59.1% | 18.0%  | 0.3   | 327.4  |
    | 2019-2021  | 56.0% | 59.1% | 8.0%   | 0.3   | 384.9  |
    | 2020-2022  | 24.0% | 74.7% | 22.0%  | 0.3   | 356.6  |
    | 2021-2023  | 30.0% | 74.7% | 12.0%  | 0.3   | 344.8  |
    | 2022-2024  | 8.0%  | 74.7% | -17.0% | 0.3   | 394.4  |
    | 2023-2025  | -8.0% | 71.6% | -55.0% | 0.2   | 377.1  |

    *   **CAGR:** Fluctuates significantly. Recent period (2023-2025) shows a negative growth rate.
    *   **MDD:**  Maximum Drawdown is high across the recent periods, indicating considerable volatility and potential losses.
    *   **Alpha:**  Alpha has been generally low or negative in several periods, with a significant negative value in the most recent period, indicating underperformance relative to the benchmark.
    *   **Beta:** Beta is relatively low, suggesting PG is less volatile than the overall market.

**Analysis:**

*   PG has significantly underperformed the S&P 500 (VOO) over the period, with a 43.8% cumulative difference.
*   The relative divergence indicates that the current underperformance is at the lower end of its historical range compared to VOO.
*   The negative alpha in recent years confirms this underperformance, suggesting that PG has not generated excess returns compared to its risk.
*   The low beta suggests lower volatility compared to the market, which could be seen as a defensive characteristic but also limits upside potential during bull markets.

**2. Recent Price Action**

*   **Current Price:** 160.305
*   **Last Market Data:** Price: 160.865, Previous Close: 161.2, Change: -0.21
*   **5-day Moving Average:** 159.867
*   **20-day Moving Average:** 160.9968
*   **60-day Moving Average:** 162.7501

**Analysis:**

*   The current price is below the 20-day and 60-day moving averages, suggesting a short-term downtrend.
*   The price is slightly above the 5-day moving average, which may indicate a minor recent recovery.
*   The minor negative change indicates a slight downward pressure on the stock in the most recent trading session.

**3. Market Risk Indicator & Expected Return**

*   **Market Risk Indicator (MRI):** 0.0579 (Low Risk)
*   **RSI:** 44.82 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.0292 (Relatively neutral momentum)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (845 shares - Very Safe - MRI:0.06)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Short-term decline)
*   **Expected Return:** 812.0% (Long-term, relative to S&P 500, if investing regularly)

**Analysis:**

*   The MRI indicates a low-risk environment for PG.
*   The RSI suggests neutral momentum.
*   The PPO also indicates relatively neutral momentum.
*   The hybrid signal suggests buying based on the current indicators and risk level.
*   The recent negative change in relative divergence indicates short-term underperformance compared to the benchmark.
*   The high expected return suggests significant long-term outperformance potential compared to the S&P 500, assuming regular investment over a 2+ year period. This figure seems unusually high and warrants further scrutiny and validation.

**4. Recent News & Significant Events**

*   **Recent Headlines:**
    *   Major business developments, regulatory changes, or market events (July 2, 2025)
    *   Analyst discussions on performance and outlook (July 4, 2025)
    *   Notable stock volatility influenced by recent news (July 1, 2025)
    *   Expert advice to monitor recent news and announcements (June 30, 2025)

**Analysis:**

*   The news suggests that PG is experiencing both opportunities and risks, with discussions of volatility and significant events impacting the stock.
*   Investors should stay informed about these developments.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-04-24 | 1.58 | 19.78 B$  |
| 2025-01-22 | 1.94 | 21.88 B$  |
| 2024-10-18 | 1.65 | 21.74 B$  |
| 2024-04-19 | 1.56 | 20.20 B$  |
| 2025-04-24 | 1.56 | 20.20 B$  |

**Analysis:**

*   The EPS and revenue figures show some variability.
*   Revenue peaked in 2025-01-22 and has since declined in the recent quarter.
*   EPS also varies, with no clear upward or downward trend.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |
| 2024-06-30   | $20.53B    | 49.60%        |
| 2024-03-31   | $20.20B    | 51.20%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |
| 2024-06-30   | $50.29B    | 6.24%  |
| 2024-03-31   | $50.06B    | 7.50%  |

**Analysis:**

*   **Revenue:** Revenue fluctuates, with a recent decrease, suggesting potential challenges in growth.
*   **Profit Margin:** Profit margins are healthy, consistently above 49%, indicating strong operational efficiency.
*   **Equity:** Equity has been growing, showing financial stability and reinvestment potential.
*   **ROE:** ROE varies but remains generally positive, reflecting the company's ability to generate profit from shareholders' equity.

**7. Overall Analysis**

*   **Underperformance:** PG has underperformed the S&P 500, as indicated by the negative alpha and cumulative return difference.
*   **Low Risk:** MRI suggests a low-risk environment.
*   **Mixed Momentum:** The RSI and PPO indicators suggest neutral momentum.
*   **Financial Health:** The company shows solid financial health with good profit margins and equity growth.
*   **Recent Challenges:** Recent earnings and revenue show some decline, which may be causing concern.
*   **Future Outlook:** The high expected return should be approached with caution until validated, but the hybrid signal suggests buying opportunities.
*   **News Events:** Monitor ongoing developments for impacts on stock performance.

**Recommendation:**

Given the underperformance, recent revenue declines, and market volatility, it's crucial to monitor PG closely. While the low-risk profile and solid financials are positive, the underperformance relative to the S&P 500 is concerning. The unusually high expected return needs further investigation. Consider a cautious approach, keeping an eye on the news and future earnings reports before making significant investment decisions.
